European Journal of Pharmaceutics and Biopharmaceutics
Research paperEffect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines
Introduction
The epithelium of the intestinal mucosa is the first significant physical and biochemical barrier to limit drug absorption from the gastrointestinal tract. This barrier has an important role as a defense mechanism against potentially harmful substances, but it also limits the bioavailability of perorally administered drugs. In addition to passive permeation properties, active uptake and efflux systems as well as intestinal metabolic enzymes have been recognized to have a significant effect on the extent of absorption [1].
The multidrug resistance protein MDR1 (P-glycoprotein) is probably the most studied efflux transporter and, although initially discovered in tumor tissues, is also present in normal human intestinal epithelium, blood–brain barrier and hepatic canalicular membranes [2]. Its physiological function in the small intestine is to protect tissues from toxins or xenobiotics by limiting their absorption. MDR1 has also been observed to limit the oral bioavailability of several drugs by the same mechanism [3]. Inhibition and induction of MDR1 are potential mechanisms for drug interactions. The presence of MDR1 at important barrier epithelia that control drug absorption, distribution and excretion makes its substrates likely candidates for drug–drug interactions. There is also considerable interindividual variation in the expression of MDR1 as well as the other efflux proteins and metabolic enzymes and, thus, in their role in limiting oral absorption. This is due to polymorphism and/or variable exposure to inductive or inhibitory food components and medicines.
The clinical importance of the above-described defense mechanisms has led to the increased interest to develop in vitro methods that can be used during drug discovery and development in order to recognize e.g. MDR1 substrates. The Caco-2 is a widely used cell line derived from human colorectal carcinoma [4]. Permeability across fully differentiated Caco-2 monolayers is considered to model intestinal absorption, since the cells represent many of the characteristics and functions (i.e. transporters and metabolic enzymes) similar to the epithelium of the small intestine [5]. Caco-2 monolayers are used to identify drugs with potential absorption problems and to select clinical drug candidates based on absorption characteristics [6].
Expression of MDR1 has been demonstrated in Caco-2 cells, but several factors have been shown to influence its expression levels and/or functionality [7]. These factors include the age in culture and level of differentiation, passage number, and exposure to modulators, such as some MDR1 substrates [8], [9]. Typically, the expression may be quite high in the lower passages and then decline at higher passage numbers [8]. Induction of functional MDR1 expression in Caco-2 cells has been successful by adding e.g. vinblastine or vincristine to the culturing medium [10], [11]. Vinblastine-induced Caco-2 cell line has even been proposed as a platform for screening MDR1 substrates [12]. However, the expression of several other efflux proteins (MRP1-6, BCRP) has been observed in Caco-2 cell lines, but the results tend to vary between different laboratories and cell batches and even cultivation lots originating from the same batch [13], [14], [15]. This creates a need for careful characterization of the Caco-2 cells in use in terms of efflux protein expression and function in order to develop a reliable in vitro model to study efflux substrates.
In this study, we examined the effects of cell age (passage number) and level of differentiation on the mRNA expression levels of efflux proteins MDR1, MRP1-6 and BCRP in Caco-2 wild type (WT) and vinblastine-treated (VBL) cell models. As considerable overlap has been observed for substrates and inhibitors of efflux proteins, variability in the expression levels of efflux proteins would affect the suitability of the cell culture for efflux activity studies of any individual efflux protein. Of similar interest was the selectivity of the induction of MDR1 with vinblastine as the co-regulation of efflux proteins and metabolizing enzymes has been suggested [16], [17], [18]. Therefore, the mRNA levels of CYP3A4 were also studied. In addition, transport experiments with rhodamine123 across differentiated Caco-2 monolayers were performed to relate mRNA results with information on the functionality of the MDR1 in Caco-2WT and Caco-2VBL cells within the studied passage range.
Section snippets
Reagents and materials
Cell culturing reagents were purchased from Euroclone (Pero, Italy) except for fetal bovine serum and HBSS/PBS 10× concentrates from Gibco Invitrogen Corporation (Carlsbad, CA, USA) and Hepes from Sigma (St. Louis, MO, USA). All the plasticware were obtained from Corning B.V. Life Sciences (Schiphol-Rijk, Netherlands). Rhodamine123 and vinblastine were from Fluka (Buchs, Switzerland) and verapamil from MP Biomedicals (Aurora, OH, USA). Materials and reagents for qRT-PCR were purchased from
Expression of the efflux proteins in Caco-2WT and Caco-2VBL cells
The expression of MRP1 was at about similar level in all the samples (Table 1). The expression levels of MDR1, MRP2, MRP3 and MRP6 were higher in differentiated than undifferentiated cells (Fig. 1). Interestingly, the mRNA level expression of MRP4 was lower in differentiated than undifferentiated cells. Differentiation did not affect the expression of MRP5, but it was somewhat higher in older passages. The expression of BCRP was somewhat lower in the undifferentiated cells. In contrast to
Discussion
During the selection of clinical drug candidates, Caco-2 cell lines are often used as platforms for screening for potential interactions related to efflux mechanisms such as MDR1 (P-glycoprotein). However, considerable overlap has been reported in the specificity of substrates and inhibitors of different efflux proteins and metabolizing enzymes. Therefore, an essential part of designing study protocols is to elucidate the effect of the growth protocol on the transporters involved in the system.
Acknowledgements
TEKES (Finnish Funding Agency for Technology) and Orion Pharma are acknowledged for funding the work of Sanna Siissalo. Special thanks to Timo Korjamo and Mika Reinisalo at the University of Kuopio for help and qRT-PCR primers.
References (33)
- et al.
Expression and function of efflux drug transporters in the intestine
Pharmacol. Ther.
(2006) - et al.
Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium
Adv. Drug Deliv. Rev.
(1997) - et al.
Functional expression of P-glycoprotein in apical membranes of human intestinal epithelial Caco-2 cells
J. Biol. Chem.
(1993) - et al.
P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels
J. Pharm. Sci.
(1998) - et al.
Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction
Eur. J. Pharm. Sci.
(2001) - et al.
Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
Adv. Drug Del. Rev.
(1997) - et al.
Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers
Biochem. Pharmacol.
(1998) - et al.
Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines
Eur. J. Pharm. Sci.
(2005) - et al.
Evaluation of cocktail approach to standardise Caco-2 permeability experiments
Eur. J. Pharm. Biopharm.
(2006) - et al.
Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833, and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein
Eur. J. Cancer
(1993)
New and better protocols for a short-term Caco-2 cell culture system
J. Pharm. Sci.
Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa
J. Biomol. Screen.
Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport
Drug Metab. Pharmacokinet.
Role of transport proteins in drug absorption, distribution and excretion
Xenobiotica
Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
J. Histochem. Cytochem.
Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture
Biol. Cell
Cited by (45)
Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream
2019, International Journal of Biological MacromoleculesCitation Excerpt :Papp (B-to-A) values of free Dox and (free Dox + verapamil) were 0.599 ± 0.016 and 0.179 ± 0.003 (×10−6 cm/s), respectively. Verapamil (100 μM), a well-known potent P-gp inhibitor, was reported to enhance the absorptive transport of P-gp substrates across the Caco-2 cell monolayers [29]. The Papp (B-to-A) value was significantly decreased when the P-gp was not affected, which can also be seen by decreasing the value of the efflux ratio (Dox-treated group = 5.381, Dox + verapamil-treated group = 1.256).
Over-passage of epithelioma papulosum cyprini (EPC) cells increased viral hemorrhagic septicemia virus (VHSV) replication
2016, Fish and Shellfish ImmunologyCitation Excerpt :Vaccines based on inactivated or attenuated viruses can be a way to prevent VHSV disease, and the efficiency of viral production is a critical factor that can determine the practical use of developed vaccines in aquaculture farms. Although established cell lines have ability to proliferate indefinitely, changes in the morphological and physiological characteristics by the increase of passage number have been reported from various mammalian cell lines [7–9]. The changed characteristics of a cell line by increasing passage number can be favorable or detrimental for viral replication.
Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers
2015, Journal of Pharmacological and Toxicological MethodsCitation Excerpt :Regarding rhodamine permeability, it was not affected by passage number in Caco-2 cells with any of the protocols, but variability increased with higher passage numbers. This result is in contradiction with the observation by Siissalo et al. (2007) who observe a clear effect of passage number in P-gp and other transporters expression in Caco-2 cell. In accordance with Siisalo et al. in MDCK and MDR P-gp functionality is increased at higher passage numbers in both protocols.
Influence of trypsinization and alternative procedures for cell preparation before RNA extraction on RNA integrity
2014, Analytical BiochemistryCitation Excerpt :Our own observations, together with the complete lack of published data dealing with the influence of cell trypsinization on RNA integrity, encouraged us to look at this problem systematically and try to find a plausible explanation for trypsin-associated degradation of RNA. Passage number has been shown to affect morphology, proliferation rate, metabolic activity, gene expression, and cell signaling in several mammalian cell lines [35–37]. HOS cell line can also be induced to differentiate into phenotypically distinct cells, namely mature mineralizing osteoblasts and adipocytes containing lipid droplets [23,24].
Preclinical pharmacokinetics and in vitro metabolism of BMS-605339: A novel HCV NS3 protease inhibitor
2014, Journal of Pharmaceutical SciencesCitation Excerpt :Bidirectional permeability studies were conducted with the monolayers obtained from P-gp expressing Caco-2 cells cultured for approximately 21 days. Because the expression of P-gp is increased with the number of passages,7 the Caco-2 permeability assay was conducted with cells from passage 21 to 40 and between 50 and 80 for the P-gp substrate and inhibitor assay. The transport medium was modified by Hank’s balanced salt solution (HBSS) containing 10 mM N-2-hydroxyethylpiperazine-N’-2- ethanesulfonic acid (HEPES) (pH 7.4 for both apical and basolateral sides).
Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS)
2013, International Journal of PharmaceuticsCitation Excerpt :The Caco-2 cell line is from a human colorectal carcinoma; its fully differentiated monolayers have been used widely as a model for studying intestinal absorption (Moore and Hirst, 2005). Since Caco-2 cells are relatively easy to culture and they express MRP2 proteins on the apical side of the monolayer, the appropriate passage and differentiation of these cells have been used in efflux studies for investigating interactions between surfactants and the MRP2 protein (Siissalo et al., 2007, 2009). However, the MRP2 protein is not the only protein that is expressed on Caco-2 cell monolayers, and other proteins like P-gp might also affect the absorption of the targeted substrate.